All IndicationsOncologyPhase 3Phase 2Phase 2Phase 2Phase 2Phase 2
🎗️
Colorectal Cancer
7
Companies
7
Drug Programs
1
Phase 3
0
Upcoming PDUFAs
Competitors
RVMD
Revolution Medicines, Inc.
RMC-6236
CLTS
EARTH LIFE SCIENCES INC
[18F]FPyQCP
ETST
Earth Science Tech, Inc.
[18F]FPyQCP
BNTX
BioNTech
autogene cevumeran
BAYRY
BAYER
Regorafenib (CT)
MRK
MERCK
Pembrolizumab/Favezelimab
SLDB
Seldane/Company Unknown
Frog Bacterium Therapy
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | RMC-6236 | Phase 3 | — | — | — |
| CLTS EARTH LIFE SCIENCES INC | [18F]FPyQCP | Phase 2 | — | — | — |
| ETST Earth Science Tech, Inc. | [18F]FPyQCP | Phase 2 | — | — | — |
| BNTX BioNTech | autogene cevumeran | Phase 2 | — | — | — |
| BAYRY BAYER | Regorafenib (CT) | Phase 2 | — | — | — |
| MRK MERCK | Pembrolizumab/Favezelimab | Phase 2 | — | — | — |
| SLDB Seldane/Company Unknown | Frog Bacterium Therapy | — | — | — | — |
Development Stage Distribution
Unknown
1
Phase 3
1
Phase 2
5
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.